
The phase 1 study of the Vaccine will enroll up to 40 healthy adult volunteers in Philadelphia at the Perelman School of Medicine at the University of Pennsylvania and Kansas City at the Center for Pharmaceutical Research. The screening of potential participants has already begun.
The initial results of the study are expected by Late Summer. The Volunteers will be given two doses of the vaccine four weeks apart. The Pre-clinical data reportedly showed promising immune response results across multiple animal models.
The Program has been funded from the Coalition for Epidemic Preparedness Innovations (CEPI) and the Bill and the Bill and Melinda Gates Foundation. It would be a great service to mankind by the Microsoft Co-founder is the vaccine is a success. Let us hope for a good news
Vishwak Sen is heading into an unusual phase of his career. Not because he has…
Avengers Endgame is proving that a film does not always need a new release to…